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AF was shown in 78% (14/18): APC only Initiated AF, not involved in the maintenance of 
AF. Triggering AF by APC was related to wave break-up at the septopulmonary bundle 
near the RSPV ostium in 55% (lO/ZO), posterior roof of LA in 35% (7120). 2) Focally 
driven AF was shown in 22% (4/18): APCs not only initiated AF but also played a role in 
the maintenance of AF. During AF, these APCs were continuously generated from the 
arrhythmogenic foci and activated the LA. The wave propagation patterns of induced AF 
were different from those of spontaneous AF in 54.5% of patients. APC originated from 
single PV was in 45% (g/20), two PVs 15% (3/20) and more than three PVs 20% (4120). 
Non-PV foci were identified in 37.5% (6116) of the patients and mostly located at the pos- 
terior roof of the LA (12.5%, 2/16). 
Conclusion: A non-contact mapping system may facilitate identification of the mecha- 
nwns and the relationship with the underlying anatomvzzal structures responsible for the 
initiation and maintenance of AF. 
1089-14 C-Reactive Protein in Atrial Fibrillation: Evidence for the 
Presence of Inflammation in the Genesis and 
Perpetuation of the Arrhythmia 
Monica Acevedo, Ramon L. Corbalan. LUIS Perez, Sandra Braun, Jaime Pereira, Teresa 
Lira, Carlos Navarrete, Catholic University Hospital, Santiago, Chile 
Background: Atrial fibrillation (AF) is associated to a number of clinlcal entities with an 
underlying acute or chronic inflammatory process. It is possible that inflammation could 
contribute to the initiation and perpetuation of this arrhythmia. 
Alms: To evaluate the presence of an inflammatory process in patients with newly diag- 
nosed non valvular AF. 
Methods: We studied 109 consecutive patients admitted for newly diagnosed AF. Forty 
patients resulted in chronic AF and 69 had paroxysmal AF. All patients had determina- 
tions of C reactive protein (CRP) at basellne and at 30 days, 68 had CRP at 1 year of fol- 
low-up. In addition the patients were evaluated clinically and with general laboratory 
tests. A transesophageal echocardiogram (TEE) was performed withln the first 24 hours 
of admission to evaluate left atrial and ventricular dimensions, LV funcbon and the pres- 
ence of spontaneous echo contrast or intracavitary thrombus. 
Results: Mean age was 67 -t 14 years and 50% were z-70 years. Hypertension was found 
I” 57%, diabetes I” 17% and cardiomyopathy in 36% of cases. A history of previous sys- 
temlc embolism was present in 6 patients. Relevant TEE findings were left atrial diameter 
>45 mm in 52%, left ventricular dysfunction in 15% and the presence of spontaneous 
echo contrast and or LA thrombus I” 53% of cases. CRP levels in the whole group were 
l.O*l.E mg/dl, 0.9k1.4 mg/dl I” patients with paroxysmal AF and I.12 2.4 mgidl in 
patients with chronic AF (p=O.OOl AF group, p=O.Ol paroxysmal AF group and p=O.Ol 
chronic AF group vs 20 normal sublects in sinus rhythm). CRP levels correlated with 
other laboratory markers of inflammation (VHS, p=O.O03 and WBC, p= 0.004) and with 
the presence of LV dysfunction in TEE (p = 0.02) in multivariate analysis. At 30 days 
there was a significant decrease in CRP both I” chronic and paroxysmal AF ( p= 0.048 
and 0.03 respectwely). At 1 year of follow up mean CRP levels in patients that were still 
in AF were 1 .&I .8 mg/dL, whereas in those with sinus rhythm were 0.5iO.5 mg/dL, p = 
0.048) 
Conclusion: This study prowdes evidence for the presence of an inflammatory process in 
patlents with newly diagnosed non valvular AF. The perslstence of inflammation is asso- 
ciated with chronic AF at 1 year of follow up. 
1089-15 Plasma Amino-Terminal Pro-B-Type Natriuretic Peptide 
Predicts Postcardioversion Reversion to Atrial 
Fibrillation 
A. Mark Richards, John G. Lainchbury, Richard W. Troughton. Gary Nicholls, Chris M 
Frampton. Timothv G. Yandle. Christchurch Cardloendocrw Research Group. 
Christchurch, New Zealand 
Background: With mounting evidence that rate control plus anticoagulation IS the treat- 
ment of choice for chronic atrial fibrillation (AF), there is a need to improve patient selec- 
tion for electrical cardioversion (CV) from AF by more accurate predlctlon of those likely 
to exhibit sustained return to sinus rhythm. 
Methods: Plasma cardiac natriuretic peptides (NPs, including ANP. BNP and pro-amino- 
terminal BNP [N-BNP]) and adrenomedullin (ADM) were assayed before, immediately 
after and six weeks aftdrcardioversion in 151 patients with chronic AF. 
Results: Plasma NPs (but not ADM) fell significantly immediately postsuccessful CV (all 
pcO.0001) but not in 15 patients in which CV failed. At SIX months postCV, 65 patients 
remained in sinus rhythm whilst 86 were in AF. Plasma NPs (but not ADM) were signifi- 
cantly higher at all three sampling times in those destined to be in AF at six months. 
Kaplan-Meier analysis indicated significant separation of AF-free suwival curves by 
median preCV and immediate postCV levels of BNP (p=O.O39 and 0.0024 respectively) 
and N-BNP (p=O.O22 and 0.010) but not ANP (p=O.O75 and 0.063) or ADM (p=O.425 and 
0.253). Tertiles of precardioversion N-BNP differed slgmficantly for risk of AF at SIX 
months (39, 60 and 70% risk in frst, second and third tertiles respectively; p=O.O06). Mul- 
tiple regression analysis indicated both pre and immediate postcardioversion levels of 
BNP (p=O.Ol and 0.009) and N-BNP (p=O.O06 and 0.011) were predictive of reversion to 
AF independent of age, left ventricular function or the prophylactic prescription of beta 
blocketslamiodarone. 
Conclusions: In patients with chronic AF, those with plasma N-BNP concentrations ele- 
vated above the lowest tertile may be more rationally treated with rate control and antico- 
agulation rather than undergoing single or serial electrlcal cardwersion. 
1089-18 C-Reactive Protein and Microalbuminuria Are 
Associated With Atrial Fibrillation 
Folkert W. Asselberqs Gilles F. Diercks. Maarten P. van den Berg, Ad J. van Boven, 
lsabelle C. van Gelder, Dirk J. van Veldhuisen. Wiek H. van Gilst, University of 
Groningen, Groningen. The Netherlands, University Hospital Groningen, Groningen, The 
Netherlands 
Background: Atrial flbrlllation (AF) is a major risk factor for stroke and cardiac events. 
Early identification of subjects at risk for AF might help to prevent the onset of AF. The 
inflammatory marker C-reactive protein (CRP) and mwoalbuminuria are easy to obtain 
risk indicators for ischemic heart disease. lschemlc heart disease is one of the most 
important predisposing factor for AF. In this study, we hypothesized that CRP and 
microalbuminuria are associated with AF. 
Methods: In a large population based survey (8501 subjects), atrial fibrillation was mea- 
sured by one 12 lead electrocardiogram and defined according to Minnesota codes 8.3.1 
and 8.3.3. Mean age was 49 + 12.7 years and 49.8% male. Microalbuminuria was 
defined as 30-300 mgi24h. High sensitive CRP was dichotomized (three lowest quartile, 
CRP< 2.97 mg/l versus the highest quartile, CRP, 2.97 mg/l). The following cardiovascu- 
lar risk factors were assessed and used in the analysis: age, sex, hypertension, hyperc- 
holesterolemia, obesity, diabetes mellitus, smoking, ischemic heart disease, and left 
ventricular hypertrophy. 
Results: Atrial fibrillation was present in 75 (0.9 %) subjects. AF was significantly associ- 
ated with the highest quartile of CRP (2.63 [1.71-4.051, p-zO.001) and microalbuminuria 
(3.46 [2.18-5.491, pcO.001). When all cardiovascular risk factors were entered simulta- 
neously, CRP (2.09 [1.29-3.401. p=O.O03) and microalbuminurla (2.08 [I .21-3.501, 
p=O.OOE) remained significantly associated with AF. The combination of the highest quar- 
tile of CRP and the presence of microalbuminuria showed a higher association with AF 
(7.36 [4.16-13.01], pcO.OOl), even after adjusting for all cardiovascular risk factors (4.07 
[2.08-7.951, p<O.OOl). 
Conclusion: In this study, we demonstrated that C-reactwe protein, microalbuminuria, 
and the combination of both are associated with atrium ffbrillation independent of cardio- 
vascular risk factors. 
1089-17 Is Atrial Fibrillation an Inflammatory Disease Reflected 
by Elevated C-Reactive Protein? 
Chloe A. Allen Mavccxk Donald L. LappB, Brian G. Crandall, Joseph 8. Muhlestein, 
Benjamin D. Home, Tami L. Bair, Qunyu Li, Sandra P. Reyna, Dale G. Renlund, Jeffrey 
L. Anderson, LDS Hospital, Salt Lake City, UT, University of Utah, Salt Lake City, UT 
Background Inflammation is implicated in the pathogenesis of cardiovascular diseases. 
C-reactive protein (CRP), a marker of systemic inflammation, predicts increased risk of 
coronary events and stroke. Atrial fibrillation (AF) is associated with cardiac structural 
changes, including atrial fibrosis, which may have an inflammatory basis. In a recent 
small retrospective study, patients (pts) with AF had higher CRP levels than controls. We 
prospectively tested the hypothesis that CRP is a risk factor for AF in a large cohort. 
Methods Consecutive pts (Nc3.357) free from myocardial infarction had a CRP level 
drawn at the time of angiography. These pts were enrolled in the Registry of the Inter- 
mountain Heart Collaborative Study between 1994-2001. Those with 21 ECG showing 
AF during the study period formed the disease group (1x347). Those with neither ECG 
nor clinical (ICD-9) evidence for AF comprised the control (C) group (n=2449). The other 
561 were excluded. CRP was measured by fluorescence polarization immunoassay 
(Abbott). Logistic regression assessed quartile (Q) of CRP and 13 other clinical and 
angiographic variables as predictors of AF. 
Results Average age was 63+12 years; 33% were women; 61% had significant core- 
nary artery disease (CAD), and 26%. no CAD; median CRP was 1.21 mg/dL. AF pts 
were older (by 7 years) and more frequently had a history of heart fatlure (HF) than C pts 
(41% vs. 10%) (both p<O.OOl). CRP was higher in AF than C pts (1.97 vs. 1.51 mg/dL, 
p<O.OOl). Q-CRP was a univariable predictor of AF (odds ratio [OR]=l.39/Q, Cl 1.25. 
1.55, p<O.OOl). After adjustmg for age and HF, the predictive value of Q-CRP was 
reduced but retained significance (OR=l.ZO/Q, Cl 1.07-I .34, p=O.OOZ). Further adjusting 
for 11 other variables had little effect (OR=1 .19/Q. CI=l.O6-1.33, p=O.O03) 
Conclusion: Increasing CRP independently predicted an Increased risk of AF among a 
large, prospectively studied patient cohort assessed anglographically. These results sup- 
port the proposal that AF pathophysiology includes an inflammatory mechanism. that ele- 
vated CRP is a new risk marker for AF propensity, and that AF therapies targeting 
inflammation are worthy of testing. 
1089-18 Altered Collagen Subpopulations and the Matrix 
Metalloproteinase Regulation in the Development of 
Atrial Fibrillation in Atrial Dysfunction 
Jun Guanggen Cui, Fardad Esmailian, Mark Plunkett, Daniel Marelli, Abbas Ardehali, 
Jonah Odim, Hillel Laks, Luyi Sen, UCLA Medical Center/UCLA School of Medicine, Los 
Angeles, CA 
BackgroundMyocardial remodeling has been found not only in ventricle. but also in 
atrium in dilated cardiomyopathy and heart failure. We hypothesize that atrlal extracellu- 
lar matw remodeling may be responsible for the AFib recurrence and maintenance in 
atria1 dysfunction. 
Methods and Results Tissue samples from 55 hearts explanted from patients with 
dilated cardiomyopathy and end-stage heart failure underwent heart transplantation were 
examined. Nineteen patients had permanent AFib (PmAF), 20 had persistent AFlb 
(PsAF) and 16 had no documented AFib (NAF). Sixteen donor leff atrium were used as 
normal control (CN). Fibrillar collagen subtype I and III distributions in the left atrium (LA) 
were exammed by lmmunofluoresent staining. LA metalloproteinase-1 and 2 (MMP-I. 
MMP-P), tissue inhibitor of metalloproteinase-1 and 2 (TIMP-I, TIMP-2) proteins were 
evaluated by western blot. Type I collagen volume fraction (CVF-I) increased significantly 
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in all patient groups (4.37i1.07% in PmAF, 3.49+1.45% in PsAF, 1.06+0.65 in NAF, 
respectively) compared to that in CN (0.41+0.13, p< O.Ol), whereas Collagen-Ill was not 
changed among all groups. CVF-I was significantly correlated with LA dimension 
(R=0.40, p=O.O26). Atrial MMP-2 was significantly increased in all failing hearts com- 
pared with Ihat in CN (0.60*0.25), but this upregulation more pronounced in PmAF 
(1.01+0.24, ~~0.05) compared to PsAF (0.63iO.32) and NAF (0.62+0.26). Concomi- 
tantly, TIMP-2 was significantly down-regulated in PmAF (0.76+0.21) and PsAF 
(0.83kO.33) compared to NAF group (1.21+0.60) and CN group (1.2OiO.49, p-zO.01). The 
TIMP-2 to MMP-2 ratio was significantly correlated with the CVF-I (Ft=0.439. pcO.001). 
No significant changes had been found in MMP-1 and TIMP-1 among all groups. 
Conclusion -Selective down-regulation of TIMP-2 along with up-regulation of MMP-2 and 
CVF-I in the atrium may result from the atria mechanical and/or volume overloading, and 
play an important role in the atrial extracellular matrix remodeling in the cardiomyopathy 
and heart failure. These alternations may contribute to the increase in the atrial heteroge- 
neity, thereby enhance the propensity to AFib recurrence and self-perpetuating. 
abnormality (ECG-LAA) has not been addressed. 
Methods: A population-based case-control study was conducted in 150 patients (aged 
70*11, 71M I79F) with first ischemic stroke and in 200 age-, gender-, and race-ethnicity- 
matched community controls. Left atrial diameter was measured by P-dimensional tran- 
sthoracic echocardiography and indexed by body surface area. ECG-LAA was assessed 
via (1) P-wave duration; (2) interpeak distance of P wave notching (P-P’); or (3) P terml- 
nal force in lead V, (PTFV,). Logistic regression analysis was pedormed to assess the 
risk of stroke associated with ECG-LAA after adjustment for the presence of other stroke 
risk factors. 
Results: Electrocardiographic finding of PFTV, >40msec mm was found to be associ- 
ated with stroke even after adjusting for stroke risk factors and for the presence of Echo- 
LAE. 
Conclusion: A significant association between electrocardiographic abnormality of left 
atrium and ischemic stroke was observed independent of possible confounding factors 
including echo-determined left atrial diameter. ECG findings should be appropriately 
taken into account to fully assess the risk of ischemic stroke associated with left atrial 
enlargement. 
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1090-l Prolonged S Wave Duration in Vl-V3 Is the Most 
Accurate EKG Diagnostic Marker for Arrhythmogenic 
Right Ventricle Dysplasia 
Khurram Nasir, Harikrishna S. Tandri, Chandra Bomma, Crystal Tichnell, Ronald D. 
Berger, Hugh Calkins, Johns Hopkins University, Baltimore, MD 
Backaround: Diagnosis of arrhythmogenic right ventricular dysplasia (ARVD) is based on 
a set of criteria proposed by the McKenna et al. EKG findings in patients meeting Task 
Force criteria have not been described in a large series of patients. The purpose of this 
study IS to systematically describe the characteristic EKG findings of patients wtth ARVD, 
as well as to evaluate the predictive accuracy of traditional and novel EKG markers for 
identifying patients with this disease. We also sought to test the hypothesis that a pro- 
longed S wave duration in Vl -V3 would be beneficial marker in diagnosing ARVD. 
Methods & Results: EKGs of 30 patients meeting the task force criteria for the diagnosis 
of ARVD and 20 age and sex matched controls were analyzed. ARVD patients compared 
to controls had a greater QRS duration in Vl-V3 (114i15 vs.93*4 ms, p~O.0001). S 
wave duration in Vl-V3 (62+12 vs. 39*6 ms. p<O.OOOl), QRS dispersion (31+9 vs. 17*7 
ms, pcO.OOOl), and QT dispersion (45+27 vs. 14+14 ms, p<O.OOOl) respectively, as well 
as higher prevalence of other known EKG markers such as epsilon wave and T wave 
inversions beyond V2 (table). The predictive value of EKG parameters is reported in the 
table. Receiver operator curve analysis identified S wave duration 250 ms in Vl-V3 as 
the most accurate EKG diagnostic marker (total predictive value=93%) for identifying 
patients with ARVD. 
Conclusion: A prolonged duration of S wave in Vi-V3 is the most accurate diagnostic 
marker for ARVD, and should be validated in further studies. 
sensi speci Positive Negative 
tivity ficity predictive value predictive value 
% % % % 
Twaveinvetsion> 73 92 92 
v2 
Epsilon wave 26 100 lcxl 
QRS duration >llO 63 100 1M) 
ms, vi-v3 
S wave duration 90 96 96 
>50 Ills. w-v3 
V?+V2+V3/ 60 72 72 
V4+V5+V6 .1.2 
QRS 23 100 loo 
dispersion>40 ms 
QT dispersion> 50 40 100 100 
Ins 
Parietal block 70 60 61 
74 
53 
69 
89 
60 
52 
56 
69 
predictive 
value % 
82 
60 
80 
93 
65 
56 
67 
74 
1090-2 Complementary Impact of Electrocardiographic and 
Echocardiographic Evidence of Left Atrium 
Enlargement In Predicting lschemic Stroke 
Shun Kohsaka. Robert R. Sciacca, Kenichi Sugioka. Ralph L. Sacco, Shunichi Homma, 
Marco R. Di Tullio, Columbia University, New York, NY 
Background: The increased risk of stroke associated with left atrial enlargement diag- 
nosed echocardiographically (Echo-LAE) is well established, but the possibility of addi- 
bona1 prognostic information provided by electrographically assessing left atrial 
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Association Between ECG-LAA and lschermc Stmke 
LAA Criteria Prevalen OR (95%CI) P - OR (95%CI ) P-VafUe 
Ce value 
Gas Cm Adjusted for Stroke Adjusted for Stroke Risk Factors 
e trol Risk Factors and Echo LA Diameter 
P wave 2.4 1.5 1.62(0.36- 0.53 1.51 (0.34-6.64) 0.59 
>120msec % % 7.24) 
P-P’40msec 40. 25.0 1.74 (0.57. 0.33 1.05 (0.57-5.35) 0.33 
8% % 5.29) 
PFTVI 54. 36.0 1.90(1.16- 0.01 1.69 (1.13-3.10) 0.01 
i40msec mm 0% % 3.14) 
1090-3 The Use of Implantable Loop Recorders in the 
Diagnosis and Management of Syncope 
DavidJ. Farwell, Nick Freemantle, Neil Sulke, Eastboume General Hospital, Eastbourne. 
United Kingdom 
Background: Implantable loop recorders (ILR) provide an opportunity to record ECG 
data from a spontaneous syncopal event. We conducted a randomised study to investi- 
gate the impact of the Reveal Plus ILR on an unselected population of patients with 
recurrent syncope. 
Methods: All patients presenting acutely with recurrent unexplained syncope over a 16- 
month period, following a basic clinical work up, were randomised to receive the ILR or 
conventional investigation. All patients were followed for at least 6 months (mean 9 
months). 
Results: 421 patients presented, 201 were eligible. median age 74, (IQ range 61-61) 
54% female, with median syncopes 3 (IQ range 2-6). 33% of ILR patients and 4% of con- 
ventional patients received an ECG diagnosis (Hazard ratio 6.93 95%CI 3.17-25.2 
p=0.0000005). 
Time to introduction of ECG directed therapy was shorter for ILR patients (hazard ratio 
7.9 95%Cl2.8-22.3 p<O.OOOl). ILR patients had fewer post randomisation investigations 
and fewer days I” hospital resulting in cost savings, f406 vs. f1210 (mean difference 
f609 95% Cl f123-f2730). There was no difference in the number of subsequent synco- 
pal episodes, mortality or quality of life. 
Conclusions: The ILR significantly increases diagnostic rates in an unselected Western 
population with recurrent syncope. There was a decrease in hospitalisation and mvesti- 
gation in the ILR patients. There was no difference in further syncopes or quality of life. 
